EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications

Valentina Raglianti iD, Maria Lucia Angelotti, Letizia De Chiara, Paola Romagnani iD

Nephrology Dialysis Transplantation · 27.02.2026 · 41 (3) · 428-436

DOI: 10.1093/ndt/gfaf156 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 15.08.2025. Verfasst von Valentina Raglianti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Autoantibodies, Membrane Proteins, Nephrotic Syndrome, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of circulating autoantibodies targeting slit diaphragm proteins—particularly nephrin, podocin and Kirrel1—has redefined the pathogenic framework of nephrotic syndrome (NS), shifting the focus from empirical, morphology-based classification to a mechanistic, biomarker-driven model. This evolution holds promise for earlier, non-invasive diagnosis, individualized risk stratification and tailored immunomodulatory therapy. However, the translation of these insights into clinical practice requires reliable serum assays but biological complexity and technical variability remain challenging. In this review we identify five hurdles to unlock the full diagnostic and therapeutic utility of anti-slit diaphragm autoantibodies. First, the low or transient serum levels of anti-nephrin antibodies reflect their rapid onset of NS and autoantibody loss into the urine, making timing of sample collection essential. Second, antibody levels closely mirror immunological activity and proteinuria levels—rising during relapse and falling in remission—rendering detection highly phase-dependent. Third, autoimmune NS are various, which complicates diagnosis. Up to 25% of pediatric and adult NS are negative for anti-nephrin immunoglobulin G (IgG) but positive for anti-podocin IgG, and anti-Kirrel1 autoimmunity, though rare, also occurs. Overlapping profiles and epitope spreading underscore the limitations of single-target assays. Fourth, assay performance is influenced by antigen fragment selection, expression system, and post-translational modifications—especially for nephrin, which is structurally complex and heavily glycosylated. Finally, combined serological and tissue-based strategies—particularly those integrating enzyme-linked immunosorbent assay (ELISA) with super-resolution microscopy are a gold standard needed to determine sensitivity and specificity of serum ELISA and reliably inform therapeutic decision-making. Here we will discuss a roadmap for the clinical implementation of anti-nephrin, anti-podocin and anti-Kirrel1 (anti-slit diaphragm) antibody testing, which lays the foundation for precision diagnostics and personalized treatment in autoimmune podocytopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesMembrane ProteinsNephrotic SyndromeIntracellular Signaling Peptides and ProteinsHumansBiomarkersTranscription FactorsAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

ELISAautoantibodiesmicroscopynephrotic syndromepodocytopathies

Substanzen

AutoantibodiesMembrane ProteinsnephrinNPHS2 proteinIntracellular Signaling Peptides and ProteinsPSIP1 protein, humanBiomarkersTranscription FactorsAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.
  • Nephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.

ORCID-Profile: Valentina Raglianti, Paola Romagnani

Förderung

  • European Union

Zitieren

APA

Raglianti, V., Angelotti, M. L., De Chiara, L., & Romagnani, P. (2026). Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications. Nephrology Dialysis Transplantation, 41(3), 428-436. https://doi.org/10.1093/ndt/gfaf156

Vancouver

Raglianti V, Angelotti ML, De Chiara L, Romagnani P. Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications. Nephrology Dialysis Transplantation. 2026;41(3):428-436. doi:10.1093/ndt/gfaf156

BibTeX
@article{Raglianti2026,
  author = {Raglianti, Valentina and Angelotti, Maria Lucia and De Chiara, Letizia and Romagnani, Paola},
  title = {Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  volume = {41},
  number = {3},
  pages = {428--436},
  doi = {10.1093/ndt/gfaf156}
}
Kostenlos starten →